Anti-VEGF therapy for the treatment of ROP

Antonio Capone Jr., Professor of Ophthalmology at Oakland University, USA, and world-renowned expert in pediatric retina, speaks about the present advancements in the treatment of Retinopathy of Prematurity and the studies behind this progress. 

While laser treatment is efficient and already standardised,  Anti-VEGF therapy has still some unpredictability in the backend of treatment. The need and timing for retreatment are still subjects of debate, however intravitreal therapy si less invasive, easier and burden-easing for the very young patient.